SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-21-017250
Filing Date
2021-05-13
Accepted
2021-05-13 16:49:16
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 nt10024341x1_s3.htm S-3 390245
2 EXHIBIT 4.3 nt10024341x1_ex4-3.htm EX-4.3 375877
3 EXHIBIT 4.4 nt10024341x1_ex4-4.htm EX-4.4 384799
4 EXHIBIT 4.5 nt10024341x1_ex4-5.htm EX-4.5 44554
5 EXHIBIT 4.6 nt10024341x1_ex4-6.htm EX-4.6 45775
6 EXHIBIT 5.1 nt10024341x1_ex5-1.htm EX-5.1 39249
7 EXHIBIT 23.1 nt10024341x1_ex23-1.htm EX-23.1 3388
8 logo_infinityx1.jpg GRAPHIC 47567
9 nt10024341x1_ex5-1image01.jpg GRAPHIC 6416
10 nt10024341x1_ex5-1image02.jpg GRAPHIC 1807
  Complete submission text file 0001140361-21-017250.txt   1362087
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-256096 | Film No.: 21920415
SIC: 2834 Pharmaceutical Preparations